ANAMBRA POLICE ACTION ON THE CULT CLASH THAT RESULTED IN THE FATAL INJURY OF FOUR PERSONS AT AFOR NAWFIA MARKET. (PHOTO). #PRESS RELEASE

Image
 ANAMBRA POLICE ACTION ON THE CULT CLASH THAT RESULTED IN THE FATAL INJURY OF FOUR PERSONS AT AFOR NAWFIA MARKET The Anambra State Police Command wishes to provide a comprehensive update on the cult-related attack that occurred on the evening of 7th December 2025 at Afor Nawfia Market, along the Onitsha–Awka Old Road. It will be recalled that operatives of the Command attached to the Special Anti-Cult Squad, Enugwu-Ukwu, had, four days earlier, acting on credible intelligence about a planned rival cult confrontation, arrested two dangerous suspects and recovered a firearm from them. The arrested suspects have been assisting the Police with valuable information aimed at preventing further cult-related violence within Awka and its environs. Despite these proactive efforts by the Command operatives, some members of the same gang, on the evening of 7th December 2025, operating in a black Lexus Jeep with registration number yet unknown, stormed Afor Nawfia Market and opened fire indiscr...

GSK CEO TO RESIGN BY THE END OF THE YEAR. (PHOTO).


 GSK CEO to resign by the end of the year

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down on Dec. 31 after more than eight years at the helm of the London-based drugmaker.

Walmsley, 56, will be succeeded by Luke Miels, currently GSK’s chief commercial officer, the company announced Monday. During her tenure, Walmsley oversaw several strategic initiatives, including the spinoff of the consumer health business Haleon, but the company’s overall performance has underwhelmed investors. GSK shares rose 3.3% to 1,534.50 pence in early trading, making it the top gainer on the London Stock Exchange.

Despite these gains, GSK’s stock has fallen 11% since Walmsley took over on April 1, 2017. Analysts say the company has delivered on financial guidance but continues to experience slow growth. Derren Nathan, head of equity research at U.K.-based Hargreaves Lansdown, noted that while GSK has achieved progress, “the share price performance has been lackluster” and growth rates remain in the single digits.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.